Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea

被引：6

作者：

Hahn, Seung Min ^{[1
,2
]}

Han, Jung Woo ^{[1
,2
]}

Kim, Jin Seok ^{[3
]}

Shim, Ye Jee ^{[4
]}

Kim, Soyon ^{[5
]}

Kim, Hugh Chul ^{[5
]}

Park, Young Shil ^{[6
]}

Lyu, Chuhl Joo ^{[1
,2
,7
]}

机构：

[1] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea

[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Dept Pediat Hematol Oncol,Coll Med, Seoul, South Korea

[3] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[4] Keimyung Univ, Dongsan Hosp, Dept Pediat, Sch Med, Daegu, South Korea

[5] Kim & Lees Internal Med Clin, Seoul, South Korea

[6] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Pediat, Coll Med, Seoul, South Korea

[7] Yonsei Univ, Severance Hosp, Coll Med, Yonsei Canc Ctr,Dept Pediat Hematol Oncol, 50-1 Yonseiro, Seoul 03722, South Korea

来源：

HAEMOPHILIA | 2023年 / 29卷 / 04期

关键词：

PROPHYLAXIS;

D O I：

10.1111/hae.14819

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1163 / 1166

页数：4

共 50 条

[21] EMICIZUMAB PROPHYLAXIS IN ADULT AND PAEDIATRIC HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS: A SINGLE CENTRE REAL WORLD EXPERIENCE
Catalano, A.
Di Gregorio, P.
Di Cocco, M. L.
Malizia, R.
Paolini, F.
Verna, S.
HAEMOPHILIA, 2021, 27 : 70 - 70
[22] Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
Mao, Qianqian
Chen, Zhenping
Liu, Guoqing
Li, Gang
Zhen, Yingzi
Cheng, Xiaoling
Li, Zekun
Yao, Wanru
Ai, Di
Li, Zhengping
Wang, Nan
Poon, Man-Chiu
Wu, Runhui
PEDIATRIC INVESTIGATION, 2024,
[23] Real-world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center
Mao Qianqian
Chen Zhenping
Liu Guoqing
Li Gang
Zhen Yingzi
Cheng Xiaoling
Li Zekun
Yao Wanru
Ai Di
Li Zhengping
Wang Nan
Poon ManChiu
Wu Runhui
儿科学研究（英文）, 2024, 08 (04)
[24] PROPHYLAXIS WITH EMICIZUMAB IN 8 CHILDREN WITH HEMOPHILIA A AND INHIBITORS: REAL-WORLD DATA OF A PORTUGUESE HEMOPHILIA CENTER
Catarino, C.
Campanico, S.
Rodrigues, F.
Pereira, A.
HAEMOPHILIA, 2020, 26 : 70 - 70
[25] Emicizumab treatment and monitoring in a paediatric cohort: real-world data
Barg, Assaf A.
Livnat, Tami
Budnik, Ivan
Avishai, Einat
Brutman-Barazani, Tami
Tamarin, Ilia
Bashari, Dalia
Misgav, Mudi
Kenet, Gili
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (02) : 282 - 290
[26] Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real-world cases to support shared decision-making
Mason, Jane A.
Young, Guy
HAEMOPHILIA, 2021, 27 (05) : 724 - 729
[27] CLINICAL BURDEN OF INHIBITORS IN HAEMOPHILIA B - USING DATA FROM CHESS II - A EUROPEAN REAL-WORLD DATA STUDY
Young, L.
Vendetti, N.
Chen, Y.
Chi, L.
Alvir, J.
Burke, T.
Asghar, S.
Winburn, I.
HAEMOPHILIA, 2021, 27 : 54 - 54
[28] Safety of recombinant activated factor VII for treatment of breakthrough bleeds in patients with congenital haemophilia A and inhibitors receiving emicizumab prophylaxis: Review of the real-world evidence
Kenet, Gili
Fujii, Teruhisa
HAEMOPHILIA, 2024, 30 (02) : 267 - 275
[29] Differences in the use of medications for treated ADHD patients between children and adults from real-world data in Korea
Cho, Yoon
Lee, Hankil
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 192 - 192
[30] Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research
Brands, Martijn R.
Taal, Elisabeth M.
Voshaar, Martijn Oude
Driessens, Mariette H. E.
Veen, Caroline M. E. van
Kruip, Marieke J. H. A.
Exter, Paul L. den
Gorkom, Britta A. P. Laros-van
Stein-Wit, Marjet A.
Fischer, Kathelijn
Meijer, Stephan
Meijer, Karina
Beijlevelt, Marlene
Fijnvandraat, Karin
Gouw, Samantha C.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2025, 9 (02)

← 1 2 3 4 5 →